Voquezna Triple Pak
Voquezna Triple Pak
- Medicine Name: Voquezna Triple Pak
- API: Vonoprazan tablets/Amoxicillin capsules/Clarithromycin tablets
- Dosage Form & Strength: 20 mg/500 mg/500 mg
- Manufactured By: Phathom Pharmaceuticals, Inc.
Voquezna Triple Pak is a co-packaged medicinal product containing vonoprazan, a PCAB or potassium-competitive acid blocker, amoxicillin, a penicillin class antibacterial, and clarithromycin, a macrolide antimicrobial, used for the treatment of adults with Helicobacter pylori (H. pylori) infection.
Recommended Dosage: The recommended dosage regimen of Voquezna Triple Pak is 20 mg vonoprazan plus 1,000 mg amoxicillin plus 500 mg clarithromycin, each given twice daily (morning and evening, 12 hours apart), either with or without meal, for 14 days.
In case a dose is missed, administer it as promptly as possible, within four hours after the missed dose. If more than four hours have passed, skip the missed dose and administer the next dose at the regularly scheduled time. Patients should continue the normal dosing schedule until the treatment is completed.
- Serious and sometimes fatal hypersensitivity reactions (such as anaphylaxis, anaphylactic shock, erythema multiforme, rash, and Henoch-Schonlein purpura) may occur with Voquezna Triple Pak. Prior to initiating therapy made careful inquiry regarding known hypersensitivity reactions to penicillins, cephalosporins, macrolide antibacterial drugs, or other allergens. Stop treatment quickly and institute suitable treatment if hypersensitivity occurs.
- Serious cutaneous adverse reactions (SCAR), including toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS), may occur with the use of Voquezna Triple Pak. Stop treatment at the initial signs/symptoms of serious cutaneous adverse reactions or other signs/symptoms of hypersensitivity and consider further assessment.
- Clostridioides difficile-associated diarrhea (CDAD) may occur with the use of nearly/almost all antibacterial agents, including amoxicillin and clarithromycin 500 mg (component of Voquezna Triple Pak). In case CDAD is confirmed, discontinue treatment. Effective fluid and electrolyte management, antibacterial treatment of C. difficile, protein supplementation, and surgical assessment need to be instituted as clinically required.
- A majority of patients with mononucleosis who receive treatment with amoxicillin (a component of Voquezna Triple Pak) develop an erythematous skin rash. Avoid use of this medicinal product in those with mononucleosis.
- Based on data from animal studies and human observational outcomes in pregnant women with the use of clarithromycin, Voquezna Triple Pak is not recommended for pregnant women except in clinical scenarios where no substitute therapy is appropriate.
What documents are required to import VOQUEZNA TRIPLE PAK to India?
VOQUEZNA TRIPLE PAK (vonoprazan; amoxicillin; clarithromycin) can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
- The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
VOQUEZNA TRIPLE PAK (vonoprazan; amoxicillin; clarithromycin) is a (prescription medicine, prescription medication, or prescription drug) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Voquezna in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
IPN (Indian Pharma Network) can facilitate the supply of VOQUEZNA TRIPLE PAK (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Voquezna Triple Pak price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the VOQUEZNA TRIPLE PAK (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Voquezna Triple Pak®?
Vonoprazan/Amoxicillin/Clarithromycin is a Generic Name for the trade name drug Voquezna Triple Pak®.
What is the Manufacturer’s Name of Voquezna Triple Pak®?
Voquezna Triple Pak® is manufactured by Phathom Pharmaceuticals, Inc.
Is Voquezna Triple Pak® approved by the FDA?
Yes, Voquezna Triple Pak® is approved by the FDA. Date of first approval: May 3, 2022.
Where can I get Voquezna Triple Pak® at the best price in India?
To get the best Voquezna tablets/capsules price in India, kindly connect with the Indian Pharma Network (a WHO GDP & ISO 9001:2008 certified company). For Voquezna®, a medical prescription is needed from a treating physician.
What is the dosage and form of Voquezna Triple Pak® supplied?
Voquezna Triple Pak® is a co-package containing:Vonoprazan Tablets, 20 mg, Amoxicillin Capsules, 500 mg, and Clarithromycin Tablets, 500 mg for oral administration.
What are the most common side effects of Voquezna Triple Pak®?
The most common side effects of Voquezna Triple Pak® are diarrhea, dysgeusia, vulvovaginal candidiasis, abdominal pain, headache, and hypertension.
How much does Voquezna Triple Pak® cost in India?
The cost of Voquezna Triple Pak in India can vary. In order to procure this medicine legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Voquezna Triple Pak®?
Store between 20°C and 25°C (68°F and 77°F). Brief exposure to 15-30°C (59-86°F) permitted. Protect it from light.
Is it safe to buy Voquezna Triple Pak® online in India?
Yes, one can buy Voquezna online in India at the lowest price from the Indian Pharma Network (IPN) if it is not (yet) registered or available in their country. We can help facilitate the supply of Voquezna® tablets and capsules through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.